What Is Bioavailability and Why Does It Matter? Bioavailability refers to the proportion of a drug that reaches...
TMLabs Blogs
Great strategies start with understanding People. Explore our TMLabs blogs for insights on HCP and Patient intelligence, workforce engagement, data science, and the latest industry news.
From Molecule to Outcome: Aligning Therapy Positioning with the Patient Journey
Diagnosis: Anchoring Awareness in Biological Reality Across disease areas with high unmet need, diagnosis is often...
Why the GLP-1 Story Keeps Changing and Why Strategy Leaders Should Pay Attention
GLP-1 receptor agonists (GLP-1s) are evolving quickly, not just in terms of clinical evidence, but in how Healthcare...
The MSL Playbook Is Broken: How Predictive Intelligence Redefines Medical Affairs Execution
Why Medical Science Liaisons need a new operating model and how predictive HCP intelligence turns scientific exchange...
AI: Driving the Future of Life Sciences Beyond 2026
Scotland’s AI Advantage: Why Edinburgh Leads the UK in Healthcare Innovation A recent Deloitte report named Edinburgh...
GLP-1 Receptor Agonists and the Future of Metabolic Health
GLP-1RAs: Rapid Disruption, Regulatory Shifts & The Rise of Intelligent Health Information In less than a...
From Patent Cliffs to Next-Gen Blockbusters: Why 2026 Demands Message Resonance at the Heart of Commercial Strategy
The Pharmaceutical Industry in 2026 stands at a critical inflection point - where scientific promise...
Pharma Marketing Crosses Into Consumer Territory
What JPM 2026 Told Us About GLP‑1s, Oncology and the New Rules of Engagement Pharma marketing has finally crossed a...
What Shifting HCP Behavior Means for Client Growth in 2026
Why Understanding HCP Behavior Is Now a Client Risk and Growth Issue As 2026 begins, the environment shaping...
2026 JPM Healthcare Conference Recap and What It Means for Healthcare Strategy
This year’s 44th Annual J.P. Morgan Healthcare Conference (JPM) brought thousands of healthcare leaders, investors and...
Why Message Resonance Is the New ROI Multiplier in Pharma Launches
In the First Two Years, Science Alone Isn’t Enough The pharmaceutical industry has never been more scientifically...
Talking Medicines Recognized in the UK AI Index 2026
We’re pleased to share that Talking Medicines has been included in the Top 1,000 UK AI Companies in the UK AI Index...